Tazarotene 0.1 % gel in the treatment of fingernail psoriasis: A double-blind, randomized, vehicle-controlled study

Cutis

Volumn 68, Issue 5, 2001, Pages 355-358

  Scher, Richard K ^a   Stiller, Matthew ^a   Isabel Zhu, Y ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; NICOTINIC ACID DERIVATIVE; TAZAROTENE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SCREENING; FEMALE; FINGER; GEL; HOSPITALIZATION; HUMAN; MALE; NAIL DISEASE; PATHOLOGY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG EVALUATION; FEMALE; FINGERS; GELS; HUMANS; MALE; NAIL DISEASES; NEW YORK; NICOTINIC ACIDS; PSORIASIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035514089     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. de Jong EM, Seegers BA, Gulinck MK, et al. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology. 1996;193:300-303.
2. Scher RK. Psoriasis of the nails. J Geriatr Dermatol. 1995;3(suppl):56-57.